Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Osteosarcoma × Pafolacianine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Sarcoma 1 Pituitary Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1

Interventions

Cyclophosphamide 14 fludarabine 5 Methotrexate 5 Leucovorin 5 Granulocyte Colony-Stimulating Factor 5 Gemcitabine 5 Filgrastim 5 Zoledronic Acid 4 Temozolomide 4 Mesna 4 Irinotecan 4 Ifosfamide 4 Etoposide 4 Cisplatin 4 Carboplatin 4 pembrolizumab 3 fludarabine phosphate 3 Doxorubicin 3 Biopsy 3 tanespimycin 2 poly ICLC 2 pegfilgrastim 2 lorukafusp alfa 2 liposomal doxorubicin 2 dinutuximab 2 cabozantinib 2 belinostat 2 Topotecan 2 Thalidomide 2 Specimen Handling 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06235125 2024-08-22

Cytalux

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡